• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Sun Pharma > May 24, 2010

      Sun recalls cholesterol drugs from US market

      Posted AtEconomictimes.indiatimes.com

      NEW DELHI: Sun Pharmaceuticals is voluntarily recalling about 27,000 bottles of anti-Cholesterol medicine Gemfibrozil tablets from the US market after impurity levels exceeded permissible limits. New Jersey-based Sun Pharmaceutical Industries Inc, a wholly-owned subsidiary of India’s most valuable drugmaker Sun Pharma is recalling 12,036 bottles containing 500 tablets and 14,670 bottles containing 60 tablets of Gemfibrozil, as per the US drug regulator USFDA website.

      Sun Pharmaceuticals declined comment on the development. USFDA said it is a Class II level recall, meaning patients who had used Sun’s products are unlikely to have any serious adverse effects. Most of the medicines expires mid-2011.

      Product recalls are quite common in the US and many companies including the big innovators company have had to pull back products from the market. Analysts say the recall will not have any significant financial impact since the product is not high revenue drug and the quantum of recall is less.

      “But such recalls are not good for a company that is trying hard to resolve regulatory issues with the American drug regulator. FDA may view this seriously,” Ranjit Kapadia VP Institutional Sales at HDFC Securities said. US-based Caraco Pharma, in which Sun owns a majority stake has received warning letter from the FDA for not addressing manufacturing irregularities at its Michigan facilities. FDA also seized its products and halted distribution.

      May 24, 2010


      Share this Article!

    Back to top^